Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PULMONARY ADENOCARCINOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 178 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hatanaka, H; Abe, Y; Naruke, M; Tokunaga, T; Oshika, Y; Kawakami, T; Osada, H; Nagata, J; Kamochi, J; Tsuchida, T; Kijima, H; Yamazaki, H; Inoue, H; Ueyama, Y; Nakamura, M
      Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    2. Schuller, HM; Plummer, HK; Bochsler, PN; Dudrick, P; Bell, JL; Harris, RE
      Co-expression of beta-adrenergic receptors and cyclooxygenase-2 in pulmonary adenocarcinoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Takanami, I; Takeuchi, K; Karuke, M
      Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma

      TUMOR BIOLOGY
    4. Pavey, SJ; Hawson, GAT; Marsh, NA
      Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma

      BLOOD COAGULATION & FIBRINOLYSIS
    5. Meuwissen, R; Linn, SC; van der Valk, M; Mooi, WJ; Berns, A
      Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

      ONCOGENE
    6. Mori, M; Rao, SK; Popper, HH; Cagle, PT; Fraire, AE
      Atypical adenomatous hyperplasia of the lung: A probable forerunner in thedevelopment of adenocarcinoma of the lung

      MODERN PATHOLOGY
    7. Gonzalez-Lois, C; Ballestin, C; Sotelo, MT; Lopez-Rios, F; Garcia-Prats, MD; Villena, V
      Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura

      HISTOPATHOLOGY
    8. Miettinen, M; Limon, J; Niezabitowski, A; Lasota, J
      Calretinin and other mesothelioma markers in synovial sarcoma - Analysis of antigenic similarities and differences with malignant mesothelioma

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    9. Carella, R; Deleonardi, G; D'Errico, A; Salerno, A; Egarter-Vigl, E; Seebacher, C; Donazzan, G; Grigioni, WF
      Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma - A study with logistic regression analysis

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    10. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer

      GYNECOLOGIC ONCOLOGY
    11. Nakahara, R; Yokose, T; Nagai, K; Nishiwaki, Y; Ochiai, A
      Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia

      THORAX
    12. Bhattacharjee, A; Richards, WG; Staunton, J; Li, C; Monti, S; Vasa, P; Ladd, C; Beheshti, J; Bueno, R; Gillette, M; Loda, M; Weber, G; Mark, EJ; Lander, ES; Wong, W; Johnson, BE; Golub, TR; Sugarbaker, DJ; Meyerson, M
      Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    13. Roberts, F; McCall, AE; Burnett, RA
      Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry

      JOURNAL OF CLINICAL PATHOLOGY
    14. Hasegawa, Y; Takanashi, S; Kanehira, Y; Tsushima, T; Imai, T; Okumura, K
      Transforming growth factor-beta 1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma

      CANCER
    15. Hecht, JL; Pinkus, JL; Weinstein, LJ; Pinkus, GS
      The value of thyroid transcription factor-1 in cytologic preparations as amarker for metastatic adenocarcinoma of lung origin

      AJCP. American journal of clinical pathology
    16. Roberts, F; Harper, CM; Downie, I; Burnett, RA
      Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma - A study of thirteen antibodies

      AJCP. American journal of clinical pathology
    17. Imlay, SP; Raab, SS
      Pleural fluid cytology: Immunocytochemistry usage patterns and significance of nondefinitive diagnoses

      DIAGNOSTIC CYTOPATHOLOGY
    18. Sato, Y; Tsuchiya, B; Urao, T; Baba, H; Shiku, H; Kodama, T; Kameya, T
      Semiquantitative immunoblot analysis of nm23-H1 and-H2 isoforms in adenocarcinomas of the lung: Prognostic significance

      PATHOLOGY INTERNATIONAL
    19. Hara, H; Iwabuchi, K; Shinada, J; Yoshimura, H; Kameya, T
      Pulmonary adenocarcinoma with heterotopic bone formation

      PATHOLOGY INTERNATIONAL
    20. Hatanaka, H; Oshika, Y; Abe, Y; Yoshida, Y; Hashimoto, T; Handa, A; Kijima, H; Yamazaki, H; Inoue, H; Ueyama, Y; Nakamura, M
      Vascularization is decreased in pulmonary adenocarcinoma expressing brain-specific angiogenesis inhibitor 1 (BAI1)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    21. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    22. Zhou, BS; Wang, TJ; Guan, P; Wu, JM
      Indoor air pollution and pulmonary adenocarcinoma among females: A case-control study in Shenyang, China

      ONCOLOGY REPORTS
    23. Takanami, I; Takeuchi, K; Naruke, M
      Expression and prognostic value of the standard CD44 protein in pulmonary adenocarcinoma

      ONCOLOGY REPORTS
    24. Whitaker, D
      The cytology of malignant mesothelioma

      CYTOPATHOLOGY
    25. Salden, M; Splinter, TAW; Peters, HA; Look, MP; Timmermans, M; van Meerbeeck, JPAM; Foekens, JA
      The urokinase-type plasminogen activator system in resected non-small-celllung cancer

      ANNALS OF ONCOLOGY
    26. Takemoto, Y; Kawahara, M; Yamamoto, S; Iuchi, K; Mori, T; Ueda, E; Tsuchiyama, T; Furuse, K
      Synchronous primary adenocarcinoma of the lung and leiomyosarcoma of the small intestine

      INTERNAL MEDICINE
    27. Tot, T
      The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract

      APMIS
    28. Porcell, AI; De Young, BR; Proca, DM; Frankel, WL
      Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers

      MODERN PATHOLOGY
    29. Cury, PM; Butcher, DN; Fisher, C; Corrin, B; Nicholson, AG
      Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura

      MODERN PATHOLOGY
    30. Moran, CA; Wick, MR; Suster, S
      The role of immunohistochemistry in the diagnosis of malignant mesothelioma

      SEMINARS IN DIAGNOSTIC PATHOLOGY
    31. Attanoos, RL; Dojcinov, SD; Webb, R; Gibbs, AR
      Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms

      HISTOPATHOLOGY
    32. Ordonez, NG
      Transitional cell carcinomas of the ovary and bladder are immunophenotypically different

      HISTOPATHOLOGY
    33. Oates, J; Edwards, C
      HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma

      HISTOPATHOLOGY
    34. Delahunt, B; Eble, JN; King, D; Bethwaite, PB; Nacey, JN; Thornton, A
      Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour

      HISTOPATHOLOGY
    35. Nakamura, M; Abe, Y; Katoh, Y; Oshika, Y; Hatanaka, H; Tsuchida, T; Yamazaki, H; Kijima, H; Inoue, H; Ueyama, Y
      A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration

      ANTICANCER RESEARCH
    36. Ordonez, NG; Mackay, B
      Brenner tumor of the ovary: A comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder

      ULTRASTRUCTURAL PATHOLOGY
    37. Kang, Y; Prentice, MA; Mariano, JM; Davarya, S; Linnoila, RI; Moody, TW; Wakefield, LM; Jakowlew, SB
      Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis

      EXPERIMENTAL LUNG RESEARCH
    38. Hosomi, Y; Yokose, T; Hirose, Y; Nakajima, R; Nagai, K; Nishiwaki, Y; Ochiai, A
      Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung

      LUNG CANCER
    39. Yokose, T; Ito, Y; Ochiai, A
      High prevalence of atypical adenomatous hyperplasia of the lung in autopsyspecimens from elderly patients with malignant neoplasms

      LUNG CANCER
    40. Zojer, N; Dekan, G; Ackermann, J; Fiegl, M; Kaufmann, H; Drach, J; Huber, H
      Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation

      LUNG CANCER
    41. Fujise, N; Nanashima, A; Taniguchi, Y; Matsuo, S; Hatano, K; Matsumoto, Y; Tagawa, Y; Ayabe, H
      Prognostic impact of Cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

      LUNG CANCER
    42. Ordonez, NG
      Epithelial mesothelioma with deciduoid features - Report of four cases

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    43. Lantuejoul, S; Laverriere, MH; Sturm, N; Moro, D; Frey, G; Brambilla, C; Brambilla, E
      NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas

      HUMAN PATHOLOGY
    44. Yoshino, I; Nakanishi, R; Kodate, M; Osaki, T; Hanagiri, T; Takenoyama, M; Yamashita, T; Imoto, H; Taga, S; Yasumoto, K
      Pleural retraction and intra-tumoral air-bronchogram as prognostic factorsfor stage I pulmonary adenocarcinoma following complete resection

      INTERNATIONAL SURGERY
    45. Takanami, I; Takeuchi, K; Naruke, M
      Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma

      CANCER
    46. Chapman, AD; Kerr, KM
      The association between atypical adenomatous hyperplasia and primary lung cancer

      BRITISH JOURNAL OF CANCER
    47. Reyes, CV; Jensen, JD; Graham, G
      Adenocarcinoma of the lung: Electron microscopy of fine-needle aspiration biopsy specimens - A review of 73 cases

      DIAGNOSTIC CYTOPATHOLOGY
    48. Laurini, JA; Castiglioni, T; Elsner, B; Avagnina, A; Ferreiro, S; Belloti, M
      Soft tissue metastasis as initial manifestation of pleural malignant mesothelioma - A case report

      INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
    49. Sato, M; Ozeki, Y; Aida, S; Oshika, Y; Deguchi, H; Ono, K; Haraguchi, S; Ogata, T; Tanaka, S
      Expression of alpha-smooth muscle actin in small bronchioloalveolar adenocarcinoma of the lung: Assessment and comparison with Noguchi criteria

      ONCOLOGY REPORTS
    50. Volm, M; Mattern, J; Koomagi, R
      Relationship of urokinase and urokinase receptor in non-small cell lung cancer to proliferation, angiogenesis, metastasis and patient survival

      ONCOLOGY REPORTS
    51. Takanami, I
      Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma

      ONCOLOGY REPORTS
    52. Pavey, SJ; Hawson, GAT; Marsh, NA
      Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma

      BLOOD COAGULATION & FIBRINOLYSIS
    53. Saez, C; Japon, MA; Ramos-Morales, F; Romero, F; Segura, DI; Tortolero, M; Pintor-Toro, JA
      hpttg is over-expressed in pituitary adenomas and other primary epithelialneoplasias

      ONCOGENE
    54. Orosz, Z; Nagy, P; Szentirmay, Z; Zalatnai, A; Hauser, P
      Epithelial mesothelioma with deciduoid features

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    55. Oreopoulos, G; Mickleborough, L; Daniel, L; De Sa, M; Merchant, N; Butany, J
      Primary pericardial mesothelioma presenting as constrictive pericarditis

      CANADIAN JOURNAL OF CARDIOLOGY
    56. Ordonez, NG; Mackay, B
      Glycogen-rich mesothelioma

      ULTRASTRUCTURAL PATHOLOGY
    57. Tomita, M; Matsuzaki, Y; Onitsuka, T
      Correlation between mast cells and survival rates in patients with pulmonary adenocarcinoma

      LUNG CANCER
    58. Khoor, A; Whitsett, JA; Stahlman, MT; Olson, SJ; Cagle, PT
      Utility of surfactant protein B precursor and thyroid transcription factor1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

      HUMAN PATHOLOGY
    59. Ordonez, NG
      The immunohistochemical diagnosis of epithelial mesothelioma

      HUMAN PATHOLOGY
    60. Kitamura, H; Oosawa, Y; Kawano, N; Kameda, Y; Hayashi, H; Nakatani, Y; Udaka, N; Ito, T; Miyazaki, K
      Basement membrane patterns, gelatinase A and tissue inhibitor of metalloproteinase-2 expressions, and stromal fibrosis during the development of peripheral lung adenocarcinoma

      HUMAN PATHOLOGY
    61. Asakura, S; Kato, H; Fujino, S; Konishi, T; Tezuka, N; Mori, A
      Role of transforming growth factor-beta 1 and decorin in development of central fibrosis in pulmonary adenocarcinoma

      HUMAN PATHOLOGY
    62. Takanami, I; Takeuchi, K; Kodaira, S
      Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: Association with angiogenesis and poor prognosis

      ONCOLOGY
    63. Sugiura, Y; Ma, LQ; Sun, B; Shimada, H; Laug, WE; Seeger, RC; DeClerck, YA
      The plasminogen-plasminogen activator (PA) system in neuroblastoma: Role of PA inhibitor-1 in metastasis

      CANCER RESEARCH
    64. Shim, KS; Kim, KH; Han, WS; Park, EB
      Elevated serum levels of transforming growth factor-beta 1 in patients with colorectal carcinoma - Its association with tumor progression and its significant decrease after curative surgical resection

      CANCER
    65. Shoji, M; Dobashi, Y; Morinaga, S; Jiang, SX; Kameya, T
      Tumor extension and cell proliferation in adenocarcinomas of the lung

      AMERICAN JOURNAL OF PATHOLOGY
    66. Niho, S; Yokose, T; Suzuki, K; Kodama, T; Nishiwaki, Y; Mukai, K
      Monoclonality of atypical adenomatous hyperplasia of the lung

      AMERICAN JOURNAL OF PATHOLOGY
    67. Ordonez, NG
      Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma - Review and update

      AJCP. American journal of clinical pathology
    68. DAUB A; SMITHMAXIE L
      CHALLENGING CASES IN INTERNAL-MEDICINE - WHATS YOUR DIAGNOSIS

      Veterinary medicine
    69. SHEN XB; WANG GX; ZHOU BS
      RELATION OF EXPOSURE TO ENVIRONMENTAL TOBACCO-SMOKE AND PULMONARY ADENOCARCINOMA IN NONSMOKING WOMEN - A CASE-CONTROL STUDY IN NANJING

      Oncology Reports
    70. TAKANAMI I; TAKEUCHI K; NARUKE M; KODAIRA S; TANAKA F; WATANABE H; RAZ A
      AUTOCRINE MOTILITY FACTOR IN PULMONARY ADENOCARCINOMAS - RESULTS OF AN IMMUNOHISTOCHEMICAL STUDY

      Tumor biology
    71. NAKAE T; HORAI T; IMAMURA F; AKEDO H; HIGASHINO K
      EXPRESSION OF CATHEPSIN-B IN SMALL-CELL LUNG-CARCINOMA CELLS IN RELATION TO IN-VITRO INVASIVENESS

      Tumor biology
    72. Nambu, Y; Iannettoni, MD; Orringer, MB; Beer, DG
      Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas

      MOLECULAR CARCINOGENESIS
    73. NAGEL H; HEMMERLEIN B; RUSCHENBURG I; HUPPE K; DROESE M
      THE VALUE OF ANTI-CALRETININ ANTIBODY IN THE DIFFERENTIAL-DIAGNOSIS OF NORMAL AND REACTIVE MESOTHELIA VERSUS METASTATIC TUMORS IN EFFUSION CYTOLOGY

      Pathology research and practice
    74. GARCIAPRATS MD; BALLESTIN C; SOTELO T; LOPEZENCUENTRA A; MAYORDOMO JI
      A COMPARATIVE-EVALUATION OF IMMUNOHISTOCHEMICAL MARKERS FOR THE DIFFERENTIAL-DIAGNOSIS OF MALIGNANT PLEURAL TUMORS

      Histopathology
    75. DILORETO C; PUGLISI F; DILAURO V; DAMANTE G; BELTRAMI CA
      TTF-1 PROTEIN EXPRESSION IN PLEURAL MALIGNANT MESOTHELIOMAS AND ADENOCARCINOMAS OF THE LUNG

      Cancer letters
    76. Chenard-Neu, MP; Kabou, A; Mechine, A; Brolly, F; Orion, B; Bellocq, JP
      Differentiation of mesothelioma and adenocarcinoma: immunoreactivity of eleven markers, including five novel antibodies

      ANNALES DE PATHOLOGIE
    77. Sharma, S; Tan, JY; Sidhu, G; Wieczorek, R; Miller, DC; Cassai, ND
      Lung adenocarcinomas metastatic to the brain with and without ultrastructural evidence of rootlets: An electron microscopic and immunohistochemical study using cytokeratins 7 and 20 and villin

      ULTRASTRUCTURAL PATHOLOGY
    78. GRAZIANO SL; KERN JA; HERNDON JE; TATUM A; BRISSON ML; MEMOLI V; SUGARBAKER D; SKARIN AT; KREISMAN H; GREEN MR
      ANALYSIS OF NEUROENDOCRINE MARKERS, HER2 AND CEA BEFORE AND AFTER CHEMOTHERAPY IN PATIENTS WITH STAGE IIIA NONSMALL CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY

      Lung cancer
    79. YANO T; FUKUYAMA Y; YOKOYAMA H; KUNINAKA S; ASOH H; KATSUDA Y; ICHINOSE Y
      HLA CLASS-I AND CLASS-II EXPRESSION OF PULMONARY ADENOCARCINOMA CELLSAND THE INFLUENCE OF INTERFERON-GAMMA

      Lung cancer
    80. HOLST VA; FINKELSTEIN S; YOUSEM SA
      BRONCHIOLOALVEOLAR ADENOCARCINOMA OF LUNG - MONOCLONAL ORIGIN FOR MULTIFOCAL DISEASE

      The American journal of surgical pathology
    81. ORDONEZ NG
      ROLE OF IMMUNOHISTOCHEMISTRY IN DISTINGUISHING EPITHELIAL PERITONEAL MESOTHELIOMAS FROM PERITONEAL AND OVARIAN SEROUS CARCINOMAS

      The American journal of surgical pathology
    82. ORDONEZ NG
      VALUE OF CYTOKERATIN-5 6 IMMUNOSTAINING IN DISTINGUISHING EPITHELIAL MESOTHELIOMA OF THE PLEURA FROM LUNG ADENOCARCINOMA/

      The American journal of surgical pathology
    83. TAN JY; SIDHU G; GRECO MA; BALLARD H; WIECZOREK R
      VILLIN, CYTOKERATIN-7, AND CYTOKERATIN-20 EXPRESSION IN PULMONARY ADENOCARCINOMA WITH ULTRASTRUCTURAL EVIDENCE OF MICROVILLI WITH ROOTLETS

      Human pathology
    84. NAKANISHI K; HIROI S; KAWAI T; SUZUKI M; TORIKATA C
      ARGYROPHILIC NUCLEOLAR-ORGANIZER REGION COUNTS AND DNA STATUS IN BRONCHIOLOALVEOLAR EPITHELIAL HYPERPLASIA AND ADENOCARCINOMA OF THE LUNG

      Human pathology
    85. Oury, TD; Hammar, SP; Roggli, VL
      Ultrastructural features of diffuse malignant mesotheliomas

      HUMAN PATHOLOGY
    86. NAMBU Y; HUGHES SJ; REHEMTULLA A; HAMSTRA D; ORRINGER MB; BEER DG
      LACK OF CELL-SURFACE FAS APO-1 EXPRESSION IN PULMONARY ADENOCARCINOMAS/

      The Journal of clinical investigation
    87. MARTINEZ CM; PIMENTEL MTY; MONTERO MB; APARICIO MB; RACAAMONDE AV; GONZALEZ IO; HERNANDO HV
      MALIGNANT DIFFUSE MESOTHELIOMA - REPORT OF 23 CASES

      Revista Clinica Espanola
    88. ALBERTINE KH; STEINER RM; RADACK DM; GOLDING DM; PETERSON D; COHN HE; FARBER JL
      ANALYSIS OF CELL-TYPE AND RADIOGRAPHIC PRESENTATION AS PREDICTORS OF THE CLINICAL COURSE OF PATIENTS WITH BRONCHIOLOALVEOLAR CELL-CARCINOMA

      Chest
    89. SHAH IA; JAYRAM L; GANI OS; FOX IS; STANLEY TM
      PAPILLARY SEROUS CARCINOMA OF THE PERITONEUM IN A MAN - A CASE-REPORT

      Cancer
    90. FETSCH PA; ABATI A; HIJAZI YM
      UTILITY OF THE ANTIBODIES CA-19-9, HBME-1, AND THROMBOMODULIN IN THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA AND ADENOCARCINOMA IN CYTOLOGY

      CANCER CYTOPATHOLOGY
    91. ORDONEZ NG
      THROMBOMODULIN EXPRESSION IN TRANSITIONAL-CELL CARCINOMA

      AJCP. American journal of clinical pathology
    92. SAKUMA N; KAMEI T; UNOKI T; OKAMURA H; ISHIHARA T
      AN AUTOPSY CASE OF DIFFUSE MALIGNANT MESOTHELIOMA OF THE PERICARDIUM

      Pathology international
    93. VISSCHER DW; YADRANDJI S; TABACZKA P; KRAUT M; SARKAR FH
      CLINICOPATHOLOGICAL ANALYSIS OF K-RAS, P53, AND ERBB-2 GENE ALTERATIONS IN PULMONARY ADENOCARCINOMA

      Diagnostic molecular pathology
    94. TAKANAMI I; KODAIRA S; TANAKA F; WATANABE H; RAZ A
      AUTOCRINE MOTILITY FACTOR-RECEPTOR EXPRESSION AS A PROGNOSTIC FACTOR IN PULMONARY ADENOCARCINOMA

      Oncology Reports
    95. DAMMRICH JR; VOLLMERS HP; SILBER RE; BUCHWALD J; PAPADOPOULOS T; MULLERHERMELINK HK
      POSTOPERATIVE PROGNOSIS OF PULMONARY ADENOCARCINOMA SUBTYPES CORRELATES WITH HLA-DR EXPRESSION AND THE NUMBER OF TUMOR-INFILTRATING CELLS

      Oncology Reports
    96. KHOOR A; WHITSETT JA; STAHLMAN MT; HALTER SA
      EXPRESSION OF SURFACTANT PROTEIN-B PRECURSOR AND SURFACTANT PROTEIN-BMESSENGER-RNA IN ADENOCARCINOMA OF THE LUNG

      Modern pathology
    97. ORDONEZ NG
      VALUE OF THROMBOMODULIN IMMUNOSTAINING IN THE DIAGNOSIS OF TRANSITIONAL-CELL CARCINOMA - A COMPARATIVE-STUDY WITH CARCINOEMBRYONIC ANTIGEN

      Histopathology
    98. ORDONEZ NG
      VALUE OF THROMBOMODULIN IMMUNOSTAINING IN THE DIAGNOSIS OF MESOTHELIOMA

      Histopathology
    99. ATTANOOS RL; GIBBS AR
      PATHOLOGY OF MALIGNANT MESOTHELIOMA

      Histopathology
    100. BATEMAN AC; ALTALIB RK; NEWMAN T; WILLIAMS JH; HERBERT A
      IMMUNOHISTOCHEMICAL PHENOTYPE OF MALIGNANT MESOTHELIOMA - PREDICTIVE VALUE OF CA125 AND HBME-1 EXPRESSION

      Histopathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 17:36:46